CD274 and neoplasm: Transferring the feces from patients to germ-free mice showed that mice receiving feces from patients who had responded to anti-PD-1 treatment had slower tumor growth and significantly higher efficacy of anti-PD-L1 immunotherapy compared to mice receiving feces from patients who had not responded to anti-PD-1 treatment.